Industry Reports

Ultimate go-to guides for reliable insights on the consumer industry…

Price: $250

Published: VARIOUS

Publisher: MarketLine

MarketLine’s Industry Profiles will help you to form a clear picture of individual sectors, including who is operating within them and how they are performing.

Concise and accurate, Industry Profiles are presented within the globally recognized Porter’s Five Forces analysis framework to help you understand and apply key insights in minutes.

They are the ideal starting point for gaining a top-level understanding of the pharmaceutical and healthcare sectors – across the globe.

Each Industry Profile includes:

• Forecasts for the market
• Market value and volume data
• Industry segmentation
• Macroeconomic analysis
• Competitor analysis
• Leading company information

Find out more & order >>

Product Insight: Country and Industry Analysis

Price: $395 (PER PROFILE)

Published: VARIOUS

Publisher: MarketLine

MarketLine’s Country and Industry Analysis Profiles provide a quick and convenient access point to information on a wide breadth of industries and the countries in which they operate – presenting a holistic overview of individual sectors and their geographic context…

Our Country and Industry Analysis Profiles Include:

• Forecasts for the market
• Market value and volume information
• Geographic and category segmentation
• Porter’s Five Forces industry analysis
• PESTLE country analysis.

Find out more & order >>

Biotechnology: Global Industry Guide

Price: $1495

Published: 30 September 2011

Publisher: MarketLine

Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Find out more & order >>

Product Insight: Company Profiles

Price: $125 (PER COMPANY PROFILE)

Published: VARIOUS

Publisher: Datamonitor

European Pharmaceutical Review in association with Datamonitor Group is pleased to introduce you to our array of company profiles available on our RESEARCH STORE – your one stop to all research needs!

Browse and search for the latest merger and acquisition activity, lists of company products and services, and key competitor information for our entire portfolio of companies now…

Our Company Profiles:

• Provide all the crucial company information required for business and competitor intelligence needs.
• Contain a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams.
• Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Find out more & order >>

Pharmaceutical Key Trends 2011: Socio-Demographic and Economic Overview

Price: $1900

Published: 13 Apr 2011

Publisher: Datamonitor

This report focuses on the socio-demographic and economic trends that are shaping the healthcare industry, and their impact on healthcare payers and the pharmaceutical industry, both directly and indirectly.

Find out more & order >>

United Kingdom: Pharmaceuticals Industry Guide 2011

Price: $795

Published: 29 March 2011

Publisher: Datamonitor

United Kingdom: Pharmaceuticals Industry Guide is an essential resource for top-level data & analysis covering the United Kingdom Pharmaceuticals industry. It includes data on market size & segmentation, textual analysis of the key trends & competitive landscape. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals & Pharmaceuticals.

Find out more & order >>

Case Study: Personalized Cancer Therapy – The era of biomarker identification and companion diagnostic co-development

Price: $1900

Published: 04 Mar 2011

Publisher: Datamonitor

The treatment of cancer has seen a dramatic shift with the addition of molecular targeted therapies. The mixed and unpredictable responses to these targeted therapies are driving the pharmaceutical industry to search for disease and patient characteristics which confer the best response rates. Identification of biomarkers and companion diagnostics will pave the way for personalized cancer therapy.

Find out more & order >>

Future Directions in Regenerative Medicine

Price: $3835

Published: 24 Feb 2011

Publisher: Business Insights

This report covers the development of therapies to replace human cells or promote their regeneration: including cell therapies, tissue engineering, drugs, and medical devices. Each company profiled has at least one project in preclinical or Phase I study. Many also have later stage or launched products, which are covered briefly to illustrate the potential of the next generation of candidates.

Find out more & order >>

The Drug Discovery Outsourcing Market

Price: $3835

Published: 07 Jan 2011

Publisher: Business Insights

This report investigates current trends and opportunities affecting decisions on whether or not to outsource drug discovery. Outsourcing to low cost offshore destinations such as China and India are examined in detail. The report also covers a variety of strategic collaborations, academic partnerships and outsourcing opportunities along with case studies.

Find out more & order >>

Pipeline Insight: Cancer Overview Malignant Melanoma, Neuroendocrine Tumors and Thyroid Cancer – New drug approvals likely after decades of little progress

Price: $11400

Published: 10 Dec 2010

Publisher: Datamonitor

There are currently 100 drugs in the pipeline for melanoma, thyroid cancer and neuroendocrine tumors with 16 in late-stage. After years of little progress there are drugs in pre-registration for each indication. The markets are smaller than other indications but not all the unmet needs will be fulfilled providing commercial opportunities for drug developers seeking to enter the markets.

Find out more & order >>

Advances in the Design and Regulation of Adaptive Clinical Trials

Price: $3835

Published: November 2010

Publisher: Business Insights

This report reviews the use of adaptive designs across all phases of development. Dose-ranging and seamless trials are explored through case studies of important adaptive trials. Regulation by the FDA and EMA is covered in detail. The report also reviews logistical and technological aspects of adaptive designs as well as presenting an outlook for their use in drug development.

Find out more & order >>

The Top 10 Biotechnology Companies: Positioning, performance and SWOT analyses

Price: $3835

Published: 23 Sep 2010

Publisher: Business Insights

The 2005-09 period was a lucrative one for the biotechnology market, as it increased at a CAGR of 12.4%. The top 10 biotech companies registered $68.1bn in sales, accounting for a market share of 73.5% and clearly demonstrating their collective strength. The top 10 players listed in order of sales are Roche, Amgen, Gilead, UCB, Biogen, Genzyme, Cephalon, CSL, Celgene and Amylin.

Find out more & order >>